Publicacións en colaboración con investigadores/as de Hospital General Universitario de Elche (9)

2023

  1. Impact of the COVID-19 pandemic on the diagnosis and treatment of onco-hematologic patients: a discussion paper

    Revista Espanola de Quimioterapia, Vol. 36, Núm. 1, pp. 1-25

2022

  1. Breakthrough infections in MPN-COVID vaccinated patients

    Blood Cancer Journal

  2. Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID-19

    American Journal of Hematology

  3. Second versus first wave of COVID-19 in patients with MPN

    Leukemia

2021

  1. Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19

    Blood Cancer Journal, Vol. 11, Núm. 2

  2. High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib

    Leukemia, Vol. 35, Núm. 2, pp. 485-493

  3. Long-term follow-up of recovered MPN patients with COVID-19

    Blood Cancer Journal

2020

  1. Early Prediction of Subsequent Molecular Response to Nilotinib in Patients with Chronic Myeloid Leukemia: Comparison of the Quantification of BCR-ABL1 Ratios Using ABL1 or GUSB Control Genes

    Journal of Molecular Diagnostics, Vol. 22, Núm. 10, pp. 1217-1224

2018

  1. Drug-to-drug interactions of tyrosine kinase inhibitors in chronic myeloid leukemia patients. Is it a real problem?

    Annals of Hematology, Vol. 97, Núm. 11, pp. 2089-2098